Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
| Image |  |
|---|---|
| Description | scientific article published on 24 July 2019 |
| Author/s |
author: Andrew W. Roberts Constantine S. Tam Jan A Burger Judith Trotman John F Seymour David Simpson |
| Publication date | July 24, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |